Role of Phototherapy in Vitiligo Treatment Market
The Vitiligo Treatment Market has seen phototherapy emerge as a cornerstone therapy, particularly for patients with extensive vitiligo or those unresponsive to topical drugs. Narrowband UVB therapy is widely recognized for its efficacy, safety, and ability to stimulate melanocyte regeneration.
Phototherapy can be used alone or in combination with topical corticosteroids and immunomodulators, improving repigmentation outcomes and reducing relapse rates. Advancements in phototherapy devices, including home-based units and targeted delivery systems, have enhanced patient convenience and treatment adherence.
Research and clinical trials are expanding the understanding of phototherapy’s optimal dosing, frequency, and combination with emerging drugs. This approach is helping dermatologists tailor treatments to individual patient needs while minimizing adverse effects.
With growing awareness and accessibility, phototherapy continues to be a critical component of vitiligo management. Companies investing in device innovation and integrating phototherapy with next-generation therapies are poised to capitalize on this evolving market segment.